Concepts (79)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Tuberculosis Vaccines | 1 | 2011 | 1 | 0.360 |
Why?
|
| Antitubercular Agents | 1 | 2011 | 12 | 0.360 |
Why?
|
| Tuberculosis, Pulmonary | 1 | 2011 | 7 | 0.360 |
Why?
|
| Biomarkers, Tumor | 2 | 2014 | 200 | 0.180 |
Why?
|
| Positive-Pressure Respiration | 1 | 2021 | 11 | 0.180 |
Why?
|
| Respiration, Artificial | 1 | 2022 | 102 | 0.170 |
Why?
|
| Intubation, Intratracheal | 1 | 2022 | 86 | 0.170 |
Why?
|
| Intensive Care Units | 1 | 2021 | 247 | 0.160 |
Why?
|
| Loss of Function Mutation | 1 | 2019 | 2 | 0.150 |
Why?
|
| Tyrosine-tRNA Ligase | 1 | 2019 | 2 | 0.150 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2019 | 3 | 0.150 |
Why?
|
| Lung Neoplasms | 2 | 2014 | 542 | 0.150 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2019 | 262 | 0.140 |
Why?
|
| Cytokines | 2 | 2014 | 213 | 0.120 |
Why?
|
| Insulin-Like Growth Factor II | 1 | 2014 | 10 | 0.110 |
Why?
|
| Insulin-Like Growth Factor Binding Proteins | 1 | 2014 | 10 | 0.110 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2014 | 55 | 0.110 |
Why?
|
| Interleukin-2 Receptor alpha Subunit | 1 | 2013 | 11 | 0.100 |
Why?
|
| Solitary Pulmonary Nodule | 1 | 2013 | 14 | 0.100 |
Why?
|
| Multiple Pulmonary Nodules | 1 | 2013 | 11 | 0.100 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2014 | 236 | 0.090 |
Why?
|
| Vaccines, Inactivated | 1 | 2011 | 1 | 0.090 |
Why?
|
| Vaccines, Subunit | 1 | 2011 | 1 | 0.090 |
Why?
|
| Vaccines, Synthetic | 1 | 2011 | 2 | 0.090 |
Why?
|
| Directly Observed Therapy | 1 | 2011 | 2 | 0.090 |
Why?
|
| Drug Resistance, Bacterial | 1 | 2011 | 53 | 0.090 |
Why?
|
| Pulmonary Aspergillosis | 1 | 2010 | 1 | 0.080 |
Why?
|
| Aspergillus fumigatus | 1 | 2010 | 2 | 0.080 |
Why?
|
| Immunocompromised Host | 1 | 2010 | 42 | 0.080 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2010 | 43 | 0.080 |
Why?
|
| Infant, Newborn | 2 | 2022 | 540 | 0.070 |
Why?
|
| Humans | 7 | 2022 | 23331 | 0.070 |
Why?
|
| Reproducibility of Results | 2 | 2021 | 594 | 0.060 |
Why?
|
| Adult | 4 | 2022 | 7070 | 0.060 |
Why?
|
| Area Under Curve | 2 | 2014 | 60 | 0.050 |
Why?
|
| ROC Curve | 2 | 2014 | 125 | 0.050 |
Why?
|
| Predictive Value of Tests | 2 | 2014 | 442 | 0.050 |
Why?
|
| Ventilators, Mechanical | 1 | 2022 | 24 | 0.050 |
Why?
|
| Suction | 1 | 2022 | 33 | 0.050 |
Why?
|
| Intermittent Positive-Pressure Ventilation | 1 | 2021 | 4 | 0.050 |
Why?
|
| Airway Management | 1 | 2022 | 15 | 0.050 |
Why?
|
| Hospital Mortality | 1 | 2021 | 133 | 0.040 |
Why?
|
| Yeasts | 1 | 2019 | 3 | 0.040 |
Why?
|
| Catalytic Domain | 1 | 2019 | 13 | 0.040 |
Why?
|
| Homozygote | 1 | 2019 | 13 | 0.040 |
Why?
|
| Pedigree | 1 | 2019 | 52 | 0.040 |
Why?
|
| Hearing Loss, Sensorineural | 1 | 2019 | 12 | 0.040 |
Why?
|
| Female | 4 | 2019 | 13124 | 0.040 |
Why?
|
| Heterozygote | 1 | 2019 | 89 | 0.040 |
Why?
|
| Young Adult | 2 | 2014 | 1674 | 0.040 |
Why?
|
| Child | 1 | 2022 | 1171 | 0.040 |
Why?
|
| Phenotype | 1 | 2019 | 257 | 0.040 |
Why?
|
| Mutation | 1 | 2019 | 328 | 0.030 |
Why?
|
| Infant | 1 | 2019 | 486 | 0.030 |
Why?
|
| Child, Preschool | 1 | 2019 | 578 | 0.030 |
Why?
|
| Aged | 3 | 2014 | 7552 | 0.030 |
Why?
|
| Male | 3 | 2019 | 12629 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2019 | 813 | 0.030 |
Why?
|
| Aged, 80 and over | 2 | 2014 | 3783 | 0.030 |
Why?
|
| Minnesota | 1 | 2014 | 6 | 0.030 |
Why?
|
| Illinois | 1 | 2014 | 221 | 0.030 |
Why?
|
| Multivariate Analysis | 1 | 2014 | 289 | 0.030 |
Why?
|
| Neoplasm Staging | 1 | 2014 | 359 | 0.030 |
Why?
|
| Chemokine CCL3 | 1 | 2013 | 8 | 0.020 |
Why?
|
| Granuloma | 1 | 2013 | 13 | 0.020 |
Why?
|
| Interleukin 1 Receptor Antagonist Protein | 1 | 2013 | 13 | 0.020 |
Why?
|
| Chemokine CXCL12 | 1 | 2013 | 9 | 0.020 |
Why?
|
| Interleukin-10 | 1 | 2013 | 18 | 0.020 |
Why?
|
| Respiratory Tract Infections | 1 | 2013 | 24 | 0.020 |
Why?
|
| Interleukin-6 | 1 | 2013 | 73 | 0.020 |
Why?
|
| Algorithms | 1 | 2014 | 314 | 0.020 |
Why?
|
| Pneumonia | 1 | 2013 | 69 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2013 | 177 | 0.020 |
Why?
|
| Middle Aged | 2 | 2014 | 8055 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2014 | 593 | 0.020 |
Why?
|
| Radiography | 1 | 2013 | 536 | 0.020 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 2010 | 14 | 0.020 |
Why?
|
| Immunosuppressive Agents | 1 | 2010 | 113 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2014 | 3040 | 0.020 |
Why?
|